Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Phillip H. Kuo; Emanuel Kanal; Ali K. Abu-Alfa; Shawn E. Cowper

doi:10.1148/radiol.2423061640

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Phillip H. Kuo, Emanuel Kanal, Ali K. Abu-Alfa, Shawn E. Cowper

Research output: Contribution to journal › Review article › peer-review

546 Scopus citations

Abstract

While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

Original language	English (US)
Pages (from-to)	647-649
Number of pages	3
Journal	Radiology
Volume	242
Issue number	3
DOIs	https://doi.org/10.1148/radiol.2423061640
State	Published - Mar 2007
Externally published	Yes

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1148/radiol.2423061640

Cite this

@article{02cad516a5734b399e61a5642fdc2f73,

title = "Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis",

abstract = "While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.",

author = "Kuo, {Phillip H.} and Emanuel Kanal and Abu-Alfa, {Ali K.} and Cowper, {Shawn E.}",

year = "2007",

month = mar,

doi = "10.1148/radiol.2423061640",

language = "English (US)",

volume = "242",

pages = "647--649",

journal = "Radiology",

issn = "0033-8419",

publisher = "Radiological Society of North America Inc.",

number = "3",

}

TY - JOUR

T1 - Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

AU - Kuo, Phillip H.

AU - Kanal, Emanuel

AU - Abu-Alfa, Ali K.

AU - Cowper, Shawn E.

PY - 2007/3

Y1 - 2007/3

N2 - While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

AB - While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

UR - http://www.scopus.com/inward/record.url?scp=33847239121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847239121&partnerID=8YFLogxK

U2 - 10.1148/radiol.2423061640

DO - 10.1148/radiol.2423061640

M3 - Review article

C2 - 17213364

AN - SCOPUS:33847239121

SN - 0033-8419

VL - 242

SP - 647

EP - 649

JO - Radiology

JF - Radiology

IS - 3

ER -

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this